Compare Elder Pharma with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA DR. REDDYS LAB ELDER PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x -0.2 22.3 - View Chart
P/BV x 0.1 3.3 3.0% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 ELDER PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
DR. REDDYS LAB
Mar-19
ELDER PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3802,875 13.2%   
Low Rs1881,888 10.0%   
Sales per share (Unadj.) Rs491.2930.2 52.8%  
Earnings per share (Unadj.) Rs-3.2117.4 -2.7%  
Cash flow per share (Unadj.) Rs14.4185.8 7.8%  
Dividends per share (Unadj.) Rs020.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs376.5844.4 44.6%  
Shares outstanding (eoy) m20.54166.07 12.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.62.6 22.6%   
Avg P/E ratio x-89.320.3 -440.1%  
P/CF ratio (eoy) x19.712.8 153.7%  
Price / Book Value ratio x0.82.8 26.7%  
Dividend payout %017.0 0.0%   
Avg Mkt Cap Rs m5,833395,496 1.5%   
No. of employees `000NA22.0 0.0%   
Total wages/salary Rs m2,17933,562 6.5%   
Avg. sales/employee Rs ThNM7,032.8-  
Avg. wages/employee Rs ThNM1,527.9-  
Avg. net profit/employee Rs ThNM887.7-  
INCOME DATA
Net Sales Rs m10,089154,482 6.5%  
Other income Rs m2573,375 7.6%   
Total revenues Rs m10,346157,857 6.6%   
Gross profit Rs m-79231,782 -2.5%  
Depreciation Rs m36111,348 3.2%   
Interest Rs m2,756889 310.0%   
Profit before tax Rs m-3,65322,920 -15.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m0438 0.0%   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1253,858 3.2%   
Profit after tax Rs m-6519,500 -0.3%  
Gross profit margin %-7.820.6 -38.2%  
Effective tax rate %-3.416.8 -20.4%   
Net profit margin %-0.612.6 -5.1%  
BALANCE SHEET DATA
Current assets Rs m9,240111,101 8.3%   
Current liabilities Rs m9,99858,973 17.0%   
Net working cap to sales %-7.533.7 -22.3%  
Current ratio x0.91.9 49.1%  
Inventory Days Days4679 58.4%  
Debtors Days Days6094 63.6%  
Net fixed assets Rs m10,124101,245 10.0%   
Share capital Rs m206830 24.8%   
"Free" reserves Rs m5,582139,406 4.0%   
Net worth Rs m7,734140,236 5.5%   
Long term debt Rs m4,88922,000 22.2%   
Total assets Rs m22,882224,656 10.2%  
Interest coverage x-0.326.8 -1.2%   
Debt to equity ratio x0.60.2 403.0%  
Sales to assets ratio x0.40.7 64.1%   
Return on assets %11.89.1 129.6%  
Return on equity %-0.813.9 -6.1%  
Return on capital %22.314.9 149.3%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m30788,673 0.3%   
Fx outflow Rs m12519,104 0.7%   
Net fx Rs m18169,569 0.3%   
CASH FLOW
From Operations Rs m11,75428,704 40.9%  
From Investments Rs m-561-7,727 7.3%  
From Financial Activity Rs m-6,762-21,326 31.7%  
Net Cashflow Rs m4,432-314 -1,411.4%  

Share Holding

Indian Promoters % 39.6 25.5 155.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 5.4 138.9%  
FIIs % 16.8 35.3 47.6%  
ADR/GDR % 0.0 18.5 -  
Free float % 36.1 15.3 235.9%  
Shareholders   16,479 75,885 21.7%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  UNICHEM LAB  ALEMBIC PHARMA  AJANTA PHARMA  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - ALEMBIC PHARMA COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS